Cohance Lifesciences Statistics

Total Valuation

BOM:543064 has a market cap or net worth of INR 403.65 billion. The enterprise value is 405.07 billion.

Market Cap	403.65B
Enterprise Value	405.07B

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	382.57M
Shares Outstanding	n/a
Shares Change (YoY)	+0.70%
Shares Change (QoQ)	+2.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	229.46M

Valuation Ratios

The trailing PE ratio is 150.69 and the forward PE ratio is 61.45.

PE Ratio	150.69
Forward PE	61.45
PS Ratio	33.71
PB Ratio	21.93
P/TBV Ratio	41.29
P/FCF Ratio	304.75
P/OCF Ratio	140.08
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 107.96, with an EV/FCF ratio of 305.83.

EV / Earnings	151.22
EV / Sales	33.82
EV / EBITDA	107.96
EV / EBIT	136.06
EV / FCF	305.83

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.15.

Current Ratio	2.43
Quick Ratio	1.57
Debt / Equity	0.15
Debt / EBITDA	0.74
Debt / FCF	2.11
Interest Coverage	24.11

Financial Efficiency

Return on equity (ROE) is 13.61% and return on invested capital (ROIC) is 8.79%.

Return on Equity (ROE)	13.61%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	8.79%
Return on Capital Employed (ROCE)	11.16%
Revenue Per Employee	10.04M
Profits Per Employee	2.25M
Employee Count	1,193
Asset Turnover	0.45
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+65.74%
50-Day Moving Average	1,106.22
200-Day Moving Average	1,156.69
Relative Strength Index (RSI)	45.35
Average Volume (20 Days)	7,153

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543064 had revenue of INR 11.98 billion and earned 2.68 billion in profits. Earnings per share was 10.45.

Revenue	11.98B
Gross Profit	8.92B
Operating Income	2.98B
Pretax Income	3.44B
Net Income	2.68B
EBITDA	3.75B
EBIT	2.98B
Earnings Per Share (EPS)	10.45

Full Income Statement

Balance Sheet

The company has 2.80 billion in cash and 2.79 billion in debt, giving a net cash position of 13.40 million.

Cash & Cash Equivalents	2.80B
Total Debt	2.79B
Net Cash	13.40M
Net Cash Per Share	n/a
Equity (Book Value)	18.41B
Book Value Per Share	66.64
Working Capital	5.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.88 billion and capital expenditures -1.56 billion, giving a free cash flow of 1.32 billion.

Operating Cash Flow	2.88B
Capital Expenditures	-1.56B
Free Cash Flow	1.32B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.51%, with operating and profit margins of 24.86% and 22.37%.

Gross Margin	74.51%
Operating Margin	24.86%
Pretax Margin	28.72%
Profit Margin	22.37%
EBITDA Margin	31.33%
EBIT Margin	24.86%
FCF Margin	11.06%

Dividends & Yields

BOM:543064 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.70%
Shareholder Yield	-0.70%
Earnings Yield	0.66%
FCF Yield	0.33%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a